Chronic kidney disease. EBSCO DynaMed website. Available at:
https://dynamed.ebscohost.com/about/about-us. Updated April 22, 2013. Accessed July 2, 2013.
Chronic kidney disease: patient information handout. American Academy of Family Physicians website. Available at:
http://familydoctor.org/online/famdocen/home/common/kidney/832.html. Updated November 2010. Accessed July 2, 2013.
Farbakhsh K, Kasiske BL. Dyslipidemias in patients who have chronic kidney disease.
Med Clin N Am.
Insulin. American Diabetes Association website. Available at:
http://www.diabetes.org/type-1-diabetes/basics.jsp. Accessed July 2, 2013.
Jain G, Campbell RC, et al. Mineralocorticoid receptor blockers and chronic kidney disease.
Clin J Am Soc Nephrol. 2009;4(10):1685-1691.
Kidney disease basics. National Kidney Disease Education Program website. Available at:
http://www.nkdep.nih.gov/patients/kidney_disease_information.htm. March 1, 2012. Accessed July 2, 2013.
National Heart, Lung, and Blood Institute.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health Publication No. 04-5230; 2004.
National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000.
Am J Kidney Dis.
2001; 37(1 Suppl 1): S182-238.
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
Am J Kid Dis.
Medication. American Diabetes Association website.
http://www.diabetes.org/type-2-diabetes/oral-medications.jsp. Accessed July 2, 2013.
Snively CS, Gutierrez C. Chronic kidney disease: prevention and treatment of common complications.
Am Fam Phys.
10/5/2010 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: European Medicines Agency. European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim. European Medicines Agency website. Available at:
http://www.ema.europa.eu/. Published September 23, 2009. Accessed October 5, 2010.
3/5/2012 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. Published February 28, 2012. Accessed March 5, 2012.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.